MedTrace Logo

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

NCT00768157 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2009-02-09

No results posted yet for this study

Summary

Most hepatocellular carcinomas are associated with hepatitis B virus, it is hypothesized that anti-viral treatment may be helpful in treating HBV-related hepatocellular carcinoma.

Conditions

Interventions

DRUG

antiviral treatment (lamivudine or entecavir)

antiviral treatment (lamivudine 100mg per day or entecavir 0.5mg per day)

PROCEDURE

radical resection of HBV-related HCC

Procedure/Surgery - radical resection of HBV-related HCC

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Jin-Qing LI, Ph.D · Sun Yat-sen University

  • Min-Shan CHEN, Ph.D · Sun Yat-sen University

  • Xiao-Jun LIN, Ph.D · Sun Yat-sen University

  • Xiang-Ming LAO, Ph.D · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-08-31
Completion
2010-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00768157 on ClinicalTrials.gov